Search
Patexia Research
Case number 1:24-cv-00053

Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc. > Summary

Court Case Number 1:24-cv-00053

Filing Date May 17, 2024

Termination Date Oct 21, 2025

Court West Virginia Northern District Court

Status Unknown

Appeal2024-1965

JudgesThomas S. Kleeh, Thomas S. Kleeh

Defendant

Plaintiff Attorneys

72

Regeneron Pharmaceuticals
Attorney Name: Alyssa J. Picard
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Andrew E. Goldsmith
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Andrew V. Trask
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Anish R. Desai
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Arthur J. Argall III
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Christopher M. Pepe
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: David I. Berl
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: David R. Pogue
Carey Douglas Kessler & Ruby PLLC

Regeneron Pharmaceuticals
Attorney Name: Elizabeth S. Weiswasser
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Ellen E. Oberwetter
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Evan T. Leo
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Grace W. Knofczynski
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Jacob E. Hartman
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Jennalee Beazley
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Jennifer Brooks Crozier
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Kathryn S. Kayali
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Kathryn E. Leicht
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Kellie C. Van Beck
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Mary Charlotte Y. Carroll
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Matthew D. Sieger
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Natalie Carol Kennedy
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Priyata Y. Patel
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Raymond S. Franks II
Carey Douglas Kessler & Ruby PLLC

Regeneron Pharmaceuticals
Attorney Name: Rhochelle Krawetz
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Rocco J. Recce
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Shaun P. Mahaffy
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Steven R. Ruby
Carey Douglas Kessler & Ruby PLLC

Regeneron Pharmaceuticals
Attorney Name: Sven Eric Henningson III
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Teagan J. Gregory
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Thomas S. Fletcher
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Tom Yu
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Zhen Lin
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Haylee Bernal Anderson
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Renee M. Griffin
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Yi Zhang
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Adam Pan
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Alyssa J. Picard
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Andrew E. Goldsmith
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Andrew V. Trask
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Arthur J. Argall III
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Christopher M. Pepe
Paul Weiss Rifkind Wharton & Garrison

Regeneron Pharmaceuticals
Attorney Name: David I. Berl
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: David R. Pogue
Carey Douglas Kessler & Ruby PLLC

Regeneron Pharmaceuticals
Attorney Name: Elizabeth S. Weiswasser
Paul Weiss Rifkind Wharton & Garrison

Regeneron Pharmaceuticals
Attorney Name: Ellen E. Oberwetter
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Evan T. Leo
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Grace W. Knofczynski
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Jacob E. Hartman
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Jennalee Beazley
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Kathryn S. Kayali
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Mary Charlotte Y. Carroll
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Priyata Y. Patel
Paul Weiss Rifkind Wharton & Garrison

Regeneron Pharmaceuticals
Attorney Name: Raymond S. Franks II
Carey Douglas Kessler & Ruby PLLC

Regeneron Pharmaceuticals
Attorney Name: Rhochelle Krawetz
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Shaun P. Mahaffy
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Steven R. Ruby
Carey Douglas Kessler & Ruby PLLC

Regeneron Pharmaceuticals
Attorney Name: Sven Eric Henningson III
Kellogg, Hansen, Todd, Figel & Frederick

Regeneron Pharmaceuticals
Attorney Name: Teagan J. Gregory
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Thomas S. Fletcher
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Anish R. Desai
Paul Weiss Rifkind Wharton & Garrison

Regeneron Pharmaceuticals
Attorney Name: Haylee Bernal Anderson
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Jennifer Brooks Crozier
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Kathryn E. Leicht
Paul Weiss Rifkind Wharton & Garrison

Regeneron Pharmaceuticals
Attorney Name: Kellie C. Van Beck
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Matthew D. Sieger
Paul Weiss Rifkind Wharton & Garrison

Regeneron Pharmaceuticals
Attorney Name: Natalie Carol Kennedy
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Renee M. Griffin
Williams & Connolly

Regeneron Pharmaceuticals
Attorney Name: Rocco J. Recce
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Tom Yu
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Yi Zhang
Weil, Gotshal & Manges

Regeneron Pharmaceuticals
Attorney Name: Zhen Lin
Weil, Gotshal & Manges

Related Patents

Doc No Title Issue date
11788102 CHO integration sites and uses thereof Oct 17, 2023
11769597 Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF Sep 26, 2023
11753459 Anti-VEGF protein compositions and methods for producing the same Sep 12, 2023
11732024 VEGF antagonist formulations suitable for intravitreal administration Aug 22, 2023
11707506 Use of a VEGF antagonist to treat angiogenic eye disorders Jul 25, 2023
11559564 Use of a VEGF antagonist to treat angiogenic eye disorders Jan 24, 2023
11555176 Cell culture medium for eukaryotic cells Jan 17, 2023
11525833 Hydrophobic interaction chromatography-coupled native mass spectrometry for antibody analysis Dec 13, 2022
11505593 Anti-VEGF protein compositions and methods for producing the same Nov 22, 2022
11332771 Serum-free cell culture medium May 17, 2022
11312936 Taurine supplemented cell culture medium and methods of use Apr 26, 2022
11253572 Use of a VEGF antagonist to treat angiogenic eye disorders Feb 22, 2022
11084865 VEGF antagonist formulations suitable for intravitreal administration Aug 10, 2021
11066458 VEGF antagonist formulations suitable for intravitreal administration Jul 20, 2021
10927342 Taurine supplemented cell culture medium and methods of use Feb 23, 2021
10888601 Use of a VEGF antagonist to treat angiogenic eye disorders Jan 12, 2021
10828345 Use of a VEGF antagonist to treat angiogenic eye disorders Nov 10, 2020
10669594 Compositions and methods for detecting a biological contaminant Jun 2, 2020
10415055 Enhanced expression and stability regions Sep 17, 2019
10130681 Use of a VEGF antagonist to treat angiogenic eye disorders Nov 20, 2018
09816110 CHO integration sites and uses thereof Nov 14, 2017
09315281 System and methods for use in dispensing biopharmaceutical materials Apr 19, 2016
09254338 Use of a VEGF antagonist to treat angiogenic eye disorders Feb 9, 2016
09222106 Enhanced expression and stability regions Dec 29, 2015
Menu